Looking Back to
Move Forward

The ancient philosophers’ explorations into the depths of the human mind drove critical questioning that resulted in the betterment of humanity. We incorporate that same insatiable curiosity and thirst for answers as we strive to advance medicine, bringing more efficient access to therapy for evolving patient needs.

On the leading edge

At Scientia Vascular, we believe that without access, therapy can not exist. Through cutting-edge innovation, we’re answering our calling to radically disrupt the way diseases of the brain are treated. Our teams have been at the forefront of neurovascular systems, pushing beyond established boundaries to deliver the products physicians and patients need most.


Scientia strives to serve humanity with medical solutions that disrupt the status quo. Through advanced technology and boundless creativity, we empower physicians to improve patient outcomes and redefine the possibilities of healthcare. We collaborate with medical professionals and employees in a shared mission to drive transformative change in the world of patient care.

Leadership Team

At Scientia Vascular, our team constantly thinks about what patients need. Collectively, our staff brings an extensive background and knowledge of clinical perspectives; manufacturing; and mechanical, biomedical, and electrical engineering to focus on new product development that meets physician and patient needs. Our management team is composed of professionals from leading companies in the endovascular field who have played important roles leading to successful mergers and acquisitions, including Precision Vascular Systems by Boston Scientific.

A unique legacy

From humble beginnings in our founder’s garage to a prolific presence in the neurovascular treatment space, Scientia has been on quite the journey. Take a walk with us down memory lane to learn more about the highlights.

The beginning

Scientia is founded in Reno, Nevada, by CEO John Lippert. Like some of the other great contemporary tech companies we've come to know and love, our work began in a humble garage. Hailing from Reno, Nevada, the next generation of microfabrication began paving the way for better access that allows for better therapies.

Photo of the beginning of scientia. Photo of a cabin in the mountains with a little bit of snow on the ground

On the move

2013 Scientia relocates to Salt Lake City as the vibrant city began to bloom. With a rich pool of talent, an emerging medical technology sector heavily steeped in biological engineering, and an international airport ten minutes from the city center, Scientia knew to jump on the opportunity of planting roots in a beautiful city where work and play intertwine.

Photo of the mountains in Utah

A first of many

Aristotle® 14 is cleared by the FDA for sale in the United States. A new generation of microfabrication, utilizing micromachining across the entirety of the nitinol tube of the microwire, is introduced to the market.

Photo of board member at a table in a meeting

Gaining strength

Aristotle® 18 gets the green light and launches in the United States with full market release in 2019. Momentum builds as physicians begin to see the possibilities of larger-diameter wires in the neurovascular space.

Photo of surgeons in the middle of a procedure

Continued growth

Aristotle® 24 enters the stage, changing the game when it comes to reliable access. Physicians experience the power of predictive response and optimized torque output combined with the softness of small microwires for the first time.

Photo of surgeons looking over a patients x-rays

Increased resources

Vivo Capital recognizes Scientia Vascular’s potential, investing in the future of providing better, more reliable access for improved patient outcomes. With such investment, Scientia was given an increased ability to resource a thriving headquarters and manufacturing site for leading access to therapy.

Photo of people working in a warehouse

The future is now

Scientia Vascular establishes a headquartered building with increased manufacturing capability. Scaling for success resulted in also needing additional warehousing space and clean room manufacturing capabilities, which were added to increase the ability to better serve patient needs.

Photo of scientist working

Something bigger

Aristotle® Colossus disrupts the market more than any other technology within the Scientia portfolio as the first ever 0.035-inch neurovascular-indicated macrowire. When paired with 0.038-inch inner-diameter catheters, it’s designed to produce increased stability for distal navigation with flexibility needed for safe interactions with the anatomy. These features make for a powerful tool when navigating tortuous anatomy and treating complex cases.

Photo of a patients xray image

Upcoming Events

No items found.

Want more?

For more of a hands on experience, schedule a demonstration of our products with one of our team members today!